Synlogic, Inc.

SYBX
$0.69 (- $0.04 - 5.48%)
Last updated: 2026-06-10 18:42 UTC
SYBX Metrics
Exchange
🇺🇸 OTC PINX
OTC Pink MarketplaceUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS87166L1008
CUSIP87166L100
Market Price0.69
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend Frequency N/A
P/E RatioN/A
EPS-0.26
Market Cap$13.7M
Book Value0.88
Price to Book1.325
Beta0.36
52w High1.96
52w Low0.9
Next Earnings DateN/A

Synlogic, Inc. trades under ticker SYBX on OTC as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US87166L1008, CUSIP 87166L100.

About the Company
Synlogic, Inc., a biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618 for the treatment of phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Winchester, Massachusetts.
Price History